Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
miR‑145‑5p is associated with pathological complete response to neoadjuvant chemotherapy and impairs cell proliferation by targeting TGFβR2 in breast cancer.
García-García F, Salinas-Vera YM, García-Vázquez R, Marchat LA, Rodríguez-Cuevas S, López-González JS, Carlos-Reyes Á, Ramos-Payán R, Aguilar-Medina M, Pérez-Plasencia C, Ruíz-García E, López-Camarillo C. García-García F, et al. Oncol Rep. 2019 Jun;41(6):3527-3534. doi: 10.3892/or.2019.7102. Epub 2019 Apr 5. Oncol Rep. 2019. PMID: 31002371
The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth.
Rodríguez-Salazar MDC, Franco-Molina MA, Mendoza-Gamboa E, Martínez-Torres AC, Zapata-Benavides P, López-González JS, Coronado-Cerda EE, Alcocer-González JM, Tamez-Guerra RS, Rodríguez-Padilla C. Rodríguez-Salazar MDC, et al. Oncol Lett. 2017 Jul;14(1):844-852. doi: 10.3892/ol.2017.6202. Epub 2017 May 18. Oncol Lett. 2017. PMID: 28693241 Free PMC article.
Cooperative multi-targeting of signaling networks by angiomiR-204 inhibits vasculogenic mimicry in breast cancer cells.
Salinas-Vera YM, Marchat LA, García-Vázquez R, González de la Rosa CH, Castañeda-Saucedo E, Tito NN, Flores CP, Pérez-Plasencia C, Cruz-Colin JL, Carlos-Reyes Á, López-González JS, Álvarez-Sánchez ME, López-Camarillo C. Salinas-Vera YM, et al. Cancer Lett. 2018 Sep 28;432:17-27. doi: 10.1016/j.canlet.2018.06.003. Epub 2018 Jun 6. Cancer Lett. 2018. PMID: 29885516
MicroRNA-143 is Associated With Pathological Complete Response and Regulates Multiple Signaling Proteins in Breast Cancer.
García-Vázquez R, Marchat LA, Ruíz-García E, Astudillo-de la Vega H, Meneses-García A, Arce-Salinas C, Bargallo-Rocha E, Carlos-Reyes Á, López-González JS, Pérez-Plasencia C, Ramos-Payán R, Aguilar-Medina M, López-Camarillo C. García-Vázquez R, et al. Technol Cancer Res Treat. 2019 Jan 1;18:1533033819827309. doi: 10.1177/1533033819827309. Technol Cancer Res Treat. 2019. PMID: 30755102 Free PMC article.
Dietary Compounds as Epigenetic Modulating Agents in Cancer.
Carlos-Reyes Á, López-González JS, Meneses-Flores M, Gallardo-Rincón D, Ruíz-García E, Marchat LA, Astudillo-de la Vega H, Hernández de la Cruz ON, López-Camarillo C. Carlos-Reyes Á, et al. Front Genet. 2019 Mar 1;10:79. doi: 10.3389/fgene.2019.00079. eCollection 2019. Front Genet. 2019. PMID: 30881375 Free PMC article. Review.
Contribution of Angiogenesis to Inflammation and Cancer.
Aguilar-Cazares D, Chavez-Dominguez R, Carlos-Reyes A, Lopez-Camarillo C, Hernadez de la Cruz ON, Lopez-Gonzalez JS. Aguilar-Cazares D, et al. Front Oncol. 2019 Dec 12;9:1399. doi: 10.3389/fonc.2019.01399. eCollection 2019. Front Oncol. 2019. PMID: 31921656 Free PMC article. Review.
Regulation Networks Driving Vasculogenic Mimicry in Solid Tumors.
Hernández de la Cruz ON, López-González JS, García-Vázquez R, Salinas-Vera YM, Muñiz-Lino MA, Aguilar-Cazares D, López-Camarillo C, Carlos-Reyes Á. Hernández de la Cruz ON, et al. Front Oncol. 2020 Jan 14;9:1419. doi: 10.3389/fonc.2019.01419. eCollection 2019. Front Oncol. 2020. PMID: 31993365 Free PMC article. Review.
40 results